Blood test to detect recurring cancer

Asaf Zviran co-founded Israel’s C2i Genomics (see here previously). It has developed a blood test that can identify whether a cancer patient will survive after the tumor has been completely removed, or whether further chemotherapy is necessary.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *